DISHMAN

Bhadra Raj Holdings Private Limited has submitted to the Exchange vide letter dated April 06, 2017 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Bhadra Raj Holdings Pvt Ltd has submitted to the Exchange, vide letter dated April 5, 2017 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Bhadra Raj Holdings Private Limited has submitted to the Exchange, vide letter dated March 24, 2017 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange vide letter dated April 2, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has informed the Exchange that has submitted to the Exchange vide letter dated April 08, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated November 19, 2014 a copy of disclosure in terms of Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

HDFC Standard Life Insurance Co. Ltd has submitted to the Exchange vide letter dated November 18, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated October 17, 2014 disclosure in terms of Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated October 2, 2014 a copy of Disclosure in terms of Regulation 13(2) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Janmejay R Vyas has submitted to the Exchange vide letter dated July 19, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated June 12, 2014 a copy of Disclosure in terms of Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

HDFC Standard Life Insurance Co. Ltd has submitted to the Exchange vide letter dated June 12, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R Vyas has submitted to the Exchange vide letter dated April 23, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Kotak Mahindra Investments Limited has submitted to the Exchange vide letter dated April 2, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated April 03, 2014 a copy of Disclosure in terms of Regulation 13(2) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated April 03, 2014 a copy of Disclosure in terms of Regulation 13(4) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Janmejay R. Vyas has submitted to the Exchange vide letter dated April 2, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated March 28, 2014 a copy of Disclosure in terms of Regulation 13(2), 13(2A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated March 20, 2014 a copy of Disclosure in terms of Regulation 13(2) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated January 27, 2014 a copy of Disclosure in terms of Regulation 13(2) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated September 17, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated September 16, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated September 05, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated September 04, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated September 03, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated September 03, 2013 a copy of Disclosure in terms of Regulation 13(4) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated September 02, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J. Vyas has submitted to the Exchange, vide letter dated August 30, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated August 29, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated August 29, 2013 a copy of Disclosure in terms of Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated August 28, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 27, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 26, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 23, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 19, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 23, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 21, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated August 21, 2013 a copy of Disclosure in terms of Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated August 16, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 14, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 21, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 19, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated August 13, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Arpit J Vyas has submitted to the Exchange vide letter dated August 13, 2013, a copy of revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated August 14, 2013 a copy of Disclosure under Regulation 13(4) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated August 08, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Arpit J Vyas has submitted to the Exchange vide letter dated August 07, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated August 06, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated August 7, 2013 a copy of Disclosure under Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated August 7, 2013 a copy of Disclosure under Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.